BI 695501 (Cyltezo®; adalimumab-adbm) in rheumatoid arthritis - VJBM

This video discusses the clinical equivalence of BI 695501 (Cyltezo®; adalimumab-adbm) and adalimumab for rheumatoid arthritis - the VOLTAIRE-RA and extension studies.

First Interchangeable Humira Biosimilar Approved

cyltezo

Home - Video Journal of Biomedicine

Uveitis Cyltezo® (adalimumab-adbm)

cyltezo

Video Journal of Biomedicine

Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE- RA equivalence study

Videos - Video Journal of Biomedicine

Adalimumab biosimilar BI 695501 (Cyltezo®; adalimumab-adbm) in rheumatoid arthritis

Evidence for Rheumatoid Arthritis

Rheumatology Dosing & Administration

Adalimumab biosimilar BI 695501 (Cyltezo®; adalimumab-adbm) in rheumatoid arthritis

Product Profile of Boehringer Ingelheim's Adalimumab Biosimilar (Cyltezo)

Home - Video Journal of Biomedicine

Adalimumab-Adbm Prices, Coupons & Savings Tips - GoodRx